The latest market report published by Credence Research, Inc. “Pressure Ulcer Treatment Products Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global pressure ulcer treatment products market was estimated at US$ 6,997.5 Mn in 2017 expanding at a CAGR of 11.6% from 2018 to 2026, to reach US$ 11,111.5 by 2026.
Browse the full report at https://www.credenceresearch.com/report/pressure-ulcer-treatment-products-market
Market Insights
A pressure ulcer or bedsore is a localized skin injury or tissue occurring due to unrelieved pressure. Pressure ulcers are a significant health problem affecting millions of individuals every year; the prevalence of pressure further rises and even proves fatal in certain countries where the healthcare infrastructure is still underdeveloped. Furthermore, the cost of treatment of pressure ulcers can be as more as 2.5 times as the cost of prevention. Management of pressure ulcers includes identification of at-risk patients and implementation of prevention measures and wound care. Innovation in the field of dressings, growing awareness, and better reimbursements for home care are the key factors that have enhanced the market size for pressure ulcer treatment products.
For many geriatric patients, pressure ulcers may become chronic in nature for no reason and may even remain for lifetime. Several grade 3 and 4 patients develop chronic wounds and may also result in fatality due to ulcer complication such as sepsis and osteomyelitis. Incidence of pressure ulcers continue to constitute as a geriatric complication. Impairments from nutritional deficiency, chronic diseases affecting multiple systems, and immobility predispose skin aging in the elderly patients, therefore increasing vulnerability to pressure ulcers. The management of pressure ulcers require a comprehensive and multidisciplinary methods. Major factors considered include patient pathologies such as lung disease, peripheral vascular disease, severity of primary illness, nutritional status, co-morbidities etc. Goals of pressure ulcer treatment include avoiding preventable circumstances. However, once an ulcer develops, proper staging of the wound and consequent rigorous treatments are required. Major treatment measures for pressure ulcers include using pressure relief devices, wound dressings and wound healing devices, tissue sealing agents and so on. Of late, methods of predicting pressure ulcer risks and preventing pressure ulcer development have received significant attention. Pressure relief materials and dressings have been improved for allowing accelerated healing; new treatments such as negative pressure wound therapy, growth factors and electrical stimulation are also receiving significant attention in the global market.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59332
For the purpose of this study, the global pressure ulcer treatment products market is classified in terms of products, wound types and usage area. Among the considered product types, wound dressings and pressure relief devices occupy the largest share in the global market. Though there is no clear leadership of any particular dressing type, it is evident that advanced wound healing products such as alginates, hydrocolloids and antimicrobials are the major dressing types that are receiving significant attention in the market.
Stage 3 and 4 wound types currently occupy the largest market hare globally, in terms of wound types. These are the most commonly evident wound types and require most extensive and prolonged treatment regimen. A typical stage 3 wound may take one to three months to heal, and stage 4 wounds may also accompany the patient through their lifetime. The requirement of advanced dressings in this wound group is also the highest, therefore generating highest revenue. Stage 1 and 2 wounds are characterized by penetration only in the skin tissue. Treatment of these wound types mainly require simple wound dressings and appropriate preventive care so as to avoid advancing to further stages.
Hospitals are the most prominent usage area for pressure ulcer treatment products. Greater patient footfall, and higher affordability for advanced products are the key factors facilitating the dominance of this segment. On the other hand, home care segment currently has the smallest market share in the global market. However, this segment shall cannibalize on the market share of hospitals due to growing preference of patients to move to home care in order to save healthcare costs.
Key Market Movements:
Our Blog: http://www.tcnindustry.com/
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
Browse the full report at https://www.credenceresearch.com/report/pressure-ulcer-treatment-products-market
Market Insights
A pressure ulcer or bedsore is a localized skin injury or tissue occurring due to unrelieved pressure. Pressure ulcers are a significant health problem affecting millions of individuals every year; the prevalence of pressure further rises and even proves fatal in certain countries where the healthcare infrastructure is still underdeveloped. Furthermore, the cost of treatment of pressure ulcers can be as more as 2.5 times as the cost of prevention. Management of pressure ulcers includes identification of at-risk patients and implementation of prevention measures and wound care. Innovation in the field of dressings, growing awareness, and better reimbursements for home care are the key factors that have enhanced the market size for pressure ulcer treatment products.
For many geriatric patients, pressure ulcers may become chronic in nature for no reason and may even remain for lifetime. Several grade 3 and 4 patients develop chronic wounds and may also result in fatality due to ulcer complication such as sepsis and osteomyelitis. Incidence of pressure ulcers continue to constitute as a geriatric complication. Impairments from nutritional deficiency, chronic diseases affecting multiple systems, and immobility predispose skin aging in the elderly patients, therefore increasing vulnerability to pressure ulcers. The management of pressure ulcers require a comprehensive and multidisciplinary methods. Major factors considered include patient pathologies such as lung disease, peripheral vascular disease, severity of primary illness, nutritional status, co-morbidities etc. Goals of pressure ulcer treatment include avoiding preventable circumstances. However, once an ulcer develops, proper staging of the wound and consequent rigorous treatments are required. Major treatment measures for pressure ulcers include using pressure relief devices, wound dressings and wound healing devices, tissue sealing agents and so on. Of late, methods of predicting pressure ulcer risks and preventing pressure ulcer development have received significant attention. Pressure relief materials and dressings have been improved for allowing accelerated healing; new treatments such as negative pressure wound therapy, growth factors and electrical stimulation are also receiving significant attention in the global market.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59332
For the purpose of this study, the global pressure ulcer treatment products market is classified in terms of products, wound types and usage area. Among the considered product types, wound dressings and pressure relief devices occupy the largest share in the global market. Though there is no clear leadership of any particular dressing type, it is evident that advanced wound healing products such as alginates, hydrocolloids and antimicrobials are the major dressing types that are receiving significant attention in the market.
Stage 3 and 4 wound types currently occupy the largest market hare globally, in terms of wound types. These are the most commonly evident wound types and require most extensive and prolonged treatment regimen. A typical stage 3 wound may take one to three months to heal, and stage 4 wounds may also accompany the patient through their lifetime. The requirement of advanced dressings in this wound group is also the highest, therefore generating highest revenue. Stage 1 and 2 wounds are characterized by penetration only in the skin tissue. Treatment of these wound types mainly require simple wound dressings and appropriate preventive care so as to avoid advancing to further stages.
Hospitals are the most prominent usage area for pressure ulcer treatment products. Greater patient footfall, and higher affordability for advanced products are the key factors facilitating the dominance of this segment. On the other hand, home care segment currently has the smallest market share in the global market. However, this segment shall cannibalize on the market share of hospitals due to growing preference of patients to move to home care in order to save healthcare costs.
Key Market Movements:
- Growing prevalence of obesity and related chronic conditions
- Technological advanced in nature of pressure relief devices and dressing products
- Intensive marketing strategies of the major market players for advanced dressings products
- Intensive research and development activities for promoting the efficacy of novel treatment products and devices
- Lucrative opportunities in viability of growth factors, hemostatic agents, negative pressure wound therapy and ultrasound therapy
- Pressure Relief Devices
- Low-tech Devices
- High-tech Devices
- Wound Dressings
- Polyurethane Film
- Hydrocolloids
- Hydrogels
- Foams
- Alginates
- Antimicrobial Dressings
- Collagen
- Others (Gauze, Dry or Wet Dressings)
- Wound Care Devices
- Negative Pressure Wound Therapy
- Others (Ultrasound, HBOT and Electromagnetic Therapy)
- Others (Hemostatic Agents, Growth Factors, etc.)
- Stage 1 & 2
- Stage 3 & 4
- Unstageable and Deep Tissue Injury
- Hospitals
- Nursing Homes
- Home Care
- North America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
- Latin America
Our Blog: http://www.tcnindustry.com/
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
No comments:
Post a Comment